These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes. Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor. Keov P; López L; Devine SM; Valant C; Lane JR; Scammells PJ; Sexton PM; Christopoulos A J Biol Chem; 2014 Aug; 289(34):23817-37. PubMed ID: 25006252 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands. De Amici M; Conti P; Fasoli E; Barocelli E; Ballabeni V; Bertoni S; Impicciatore M; Roth BL; Ernsberger P; De Micheli C Farmaco; 2003 Sep; 58(9):739-48. PubMed ID: 13679167 [TBL] [Abstract][Full Text] [Related]
18. The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors. Volpato D; Kauk M; Messerer R; Bermudez M; Wolber G; Bock A; Hoffmann C; Holzgrabe U ACS Omega; 2020 Dec; 5(49):31706-31715. PubMed ID: 33344823 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines. Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]